Brief: Mega Genomics Expects FY2025 Revenue Of RMB240-250 Million
20/03/2026 15:17
March 20 (Reuters) - Mega Genomics Ltd 6667.HK: EXPECTS FY2025 REVENUE OF RMB240-250 MILLION EXPECTS FY2025 PROFIT ATTRIBUTABLE OF RMB25-28 MILLION EXPECTED PROFIT RESULT DUE TO CREDIT IMPAIRMENT LOSSES IN FY, OTHERS Further company coverage: 6667.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mega Genomics
See all newsBrief: Mega Genomics Expects FY2025 Revenue Of RMB240-250 Million
Brief: Mega Genomics Says Trading In Shares Of Company Will Be Suspended From On 1 April
Brief: Mega Genomics Announces Termination Of Huang Yufeng's Role As Chief Executive Officer
Brief: Meinian Onehealth Healthcare Signs Genetic Testing Project Cooperation Agreement
Brief: Mega Genomics Sees Loss Attributable For Year RMB13 Million To RMB22 Million